Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
There are several generic versions of the Laos Lucius version of capmatinibMET dysregulation occurs in up to 26% of patients with non-small cell lung cancer (NSCLC) after treatment···【more】
Article source：Captain MedicineRelease date：2024-11-25Recommended：526
Gilteritinib, as a FLT3 inhibitor, has demonstrated significant clinical activity in patients with FLT3-mutated (FLT3mut) relapsed/refractory (R/R) acute myeloid leukemia (AML). To···【more】
Article source：Captain MedicineRelease date：2024-11-22Recommended：463
This study aims to investigate the safety and efficacy of the combination of gilteritinib as a strategy to bridge to allogeneic hematopoietic stem cell transplantation (allo-HSCT) ···【more】
Article source：Captain MedicineRelease date：2024-11-22Recommended：538
What are the side effects of gilitinib?The FLT3 inhibitor Gilteritinib (Xospata) has resulted in significant survival improvements in patients with relapsed/refractory acute myeloi···【more】
Article source：Captain MedicineRelease date：2024-11-21Recommended：461
Gireltinib is primarily effective in acute myeloid leukemia (AML), particularly in relapsed or refractory AML harboring FLT3 mutations.InhibitionGireltinib is a novel, highly selec···【more】
Article source：Captain MedicineRelease date：2024-11-21Recommended：447
Patients with non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) rearrangement or ROS proto-oncogene 1 (ROS1) rearrangement are generally sensitive to tyrosin···【more】
Article source：Captain MedicineRelease date：2024-11-20Recommended：496
Lorlatinib is a highly potent third-generation ALK and ROS1 tyrosine kinase inhibitor with good brain penetration and broad coverage of ALK mutations. In a phase 1 study, it showed···【more】
Article source：Captain MedicineRelease date：2024-11-20Recommended：562
The tropomyosin receptor kinase (TRK) fusion protein produced by the fusion of the neurotrophic tyrosine receptor kinase (NTRK) gene is a major oncogenic driver that is rare in a v···【more】
Article source：Captain MedicineRelease date：2024-11-19Recommended：502
How to buy generic larotrectinib?Vitrakvi, a highly selective oral tropomyosin receptor kinase (TRK) inhibitor, larotrectinib, has demonstrated significant activity in adult and pe···【more】
Article source：Captain MedicineRelease date：2024-11-19Recommended：406
1. Product IngredientsEntrectinib is a small molecule tyrosine kinase inhibitor with the chemical name N-(4-(3-(4-(6-(2-fluoro-4-(trifluoromethyl)phenyl)thiazol-2-yl)thiazol-2-yl)p···【more】
Article source：Captain MedicineRelease date：2024-11-18Recommended：538
1. Product IngredientsThe chemical name of afatinib is N-{4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl}-2-(dimethylamino)acetamide, the molecular for···【more】
Article source：Captain MedicineRelease date：2024-11-18Recommended：439
In a phase 1 study, sotorasib showed anticancer activity in patients with advanced solid tumors with KRAS p.G12C mutations, and particularly promising anticancer activity was obser···【more】
Article source：Captain MedicineRelease date：2024-11-15Recommended：420
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8542025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10502024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3142026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4072026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：6012026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5772026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4592026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6092026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
